{"version":"1.0","type":"link","title":"Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.","author_name":"Tree AC 외","author_url":"https://prs-insight.online/author/Tree%20AC","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/137759","thumbnail_width":1200,"thumbnail_height":630}